Navigation Links
LS9, Inc. Appoints Bill Haywood Chief Executive Officer

SOUTH SAN FRANCISCO, Calif., Oct. 8 /PRNewswire/ -- LS9, Inc., the Renewable Petroleum Company(TM), today announces it has appointed Bill Haywood as Chief Executive Officer. Mr. Haywood brings over 30 years of experience in the fuels manufacturing business and a proven track record of planning, engineering, execution and start-up of major projects within the energy sector.

"The coming year will be pivotal to LS9 as the company delivers significant achievements in the development of second-generation biofuels," said Noubar Afeyan, Managing Partner of Flagship Ventures and Chairman of the LS9 Board of Directors. "Bill brings with him the ideal combination of project development, organizational optimization and investment management expertise the company needs as it transitions from development to production. His extensive relationships in the transportation fuels sector and his deep understanding of strategic partnerships are an ideal complement to the talented scientific team at LS9. The Board is extremely pleased to have Bill at the helm of the company."

Prior to joining LS9, Mr. Haywood served as Senior Vice President of Refining for Tesoro Petroleum, where he was responsible for seven refineries and over $20 billion in revenue. Under his leadership, Tesoro became a leading independent refiner by integrating refinery acquisitions, driving operational excellence and building over $1 billion in capital projects. During this period, shareholder value increased by more than 86%.

"I can't think of a more exciting opportunity than joining LS9 as we prepare to move this important technology to commercial production and become the first advanced biofuels company to reach the market," said Mr. Haywood. "I look forward to merging knowledge of the traditional transportation fuels business with synthetic biology to help bring LS9's renewable fuels and chemicals into the pipeline and to the consumer."

About LS9

LS9, Inc., the Renewable Petroleum Company(TM), is a privately-held industrial biotechnology company pursuing the commercial development of renewable fuels and chemicals. LS9 is applying synthetic biology to produce proprietary biofuels that are compatible with existing fuel distribution and consumer infrastructure and high value industrial chemicals. LS9 is the pioneer in the commercial development of fermentation derived hydrocarbon biofuels and its patent-pending Renewable Petroleum(TM) products are custom engineered in the lab to address immediate market needs for clean energy alternatives to petroleum. The company was founded in 2005 and venture capital firms Flagship Ventures, Khosla Ventures, and Lightspeed Venture Partners have provided funding to date. LS9 is headquartered in South San Francisco, California.

Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecker to Board
2. CPC of America, Inc. to Explore Strategic Alternatives; Appoints FTI Capital Advisors to Assess Potential Opportunities
3. Orexigen(R) Therapeutics Appoints Dennis Kim, M.D., as Senior Vice President, Head of Obesity and Metabolic Disorders
4. Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
5. ACORN Contract Research Organization Appoints Tara Webb as Senior Director of CRO Business Development
6. Neurofocus Appoints Stephen Kosslyn to Its Advisory Board
7. Cytochroma appoints Steven I. Engel as Vice President of Regulatory Affairs and Quality Assurance
8. Exosome Diagnostics Appoints Johan Skog, Ph.D., as Director of Genetics Research
9. Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors
10. China Yingxia International, Inc. Appoints New Vice President of Finance
11. SoluBest Appoints Michael Sheckler, MBA, as CEO
Post Your Comments:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... operations for Amgen, will join the faculty of the University of North ... adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, one ... of their brand, UP4™ Probiotics, into Target stores nationwide. The company, which has ... add Target to its list of well-respected retailers. This list includes such fine ...
(Date:6/23/2016)... -- Houston Methodist Willowbrook Hospital has signed a ... serve as their official health care provider. As ... provide sponsorship support, athletic training services, and most ... athletes and families. "We are excited ... to bring Houston Methodist quality services and programs ...
Breaking Biology Technology:
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: ) , ... but it also plays a fundamental part in enabling and ...
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:3/31/2016)... March 31, 2016  Genomics firm Nabsys has completed ... Barrett Bready , M.D., who returned to the ... original technical leadership team, including Chief Technology Officer, ... Development, Steve Nurnberg and Vice President of Software and ... company. Dr. Bready served as CEO of ...
Breaking Biology News(10 mins):